WuXi Biologics (Cayman)

(OTC) WXIBF

Current Price$4.18

Market Cap$17.31B

Since IPO (2018)-39%

5 Year-70%

1 Year+39%

1 Month-9%

WuXi Biologics (Cayman) Financials at a Glance

Market Cap

$17.31B

Revenue (TTM)

$40.27B

Net Income (TTM)

$8.22B

EPS (TTM)

$0.16

P/E Ratio

24.99

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$4.18

Volume

457

Open

$4.18

Price

$4.18

Volume

457

Open

$4.18

Previous Close

$4.18

Daily Range

$4.18 - $4.18

52-Week Range

$2.85 - $5.61

Dividend

$0.00

Beta (Volatility)

0.43 (Low)

Price

$4.18

Volume

457

Open

$4.18

Previous Close

$4.18

Daily Range

$4.18 - $4.18

52-Week Range

$2.85 - $5.61

WXIBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi Biologics (Cayman)

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,252

CEO

Zhi Sheng Chen, PhD

Website

www.wuxibiologics.com

Headquarters

Wuxi, 214092, CN

WXIBF Financials

Key Financial Metrics (TTM)

Gross Margin

46%

Operating Margin

30%

Net Income Margin

23%

Return on Equity

11%

Return on Capital

12%

Return on Assets

Earnings Yield

4.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.31B

Shares Outstanding

4.14B

Volume

457

Avg. Volume

5.53K

Financials (TTM)

Gross Profit

$9.76B

Operating Income

$6.47B

EBITDA

$8.17B

Operating Cash Flow

$6.39B

Capital Expenditure

$3.59B

Free Cash Flow

$2.80B

Cash & ST Invst.

$15.75B

Total Debt

$3.11B

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$11.64B

+36.3%

Gross Profit

$5.67B

+73.5%

Gross Margin

48.71%

N/A

Market Cap

$17.31B

N/A

Market Cap/Employee

$1.38M

N/A

Employees

12,575

N/A

Net Income

$2.53B

+123.0%

EBITDA

$4.73B

+122.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$12.64B

+89.2%

Accounts Receivable

$8.90B

+43.9%

Inventory

$1.44B

-18.4%

Long Term Debt

$1.85B

-51.7%

Short Term Debt

$1.26B

+71.8%

Return on Assets

7.70%

N/A

Return on Invested Capital

11.98%

N/A

Free Cash Flow

$2.79B

+1176.6%

Operating Cash Flow

$4.60B

+97.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IVBXFInnovent Biologics, Inc.

IVBXFInnovent Biologics, Inc.$10.34-0.08%

SAUHYStraumann Holding AG

SAUHYStraumann Holding AG$11.39-0.70%

GNMSFGenmab A/S

GNMSFGenmab A/S$258.12-4.22%

SAUHFStraumann Holding AG

SAUHFStraumann Holding AG$118.20+8.95%

ORINYOrion Oyj

ORINYOrion Oyj$37.99+0.00%

SBHMYSino Biopharmaceutical Limited

SBHMYSino Biopharmaceutical Limited$14.29+0.00%

SBMFFSino Biopharmaceutical Limited

SBMFFSino Biopharmaceutical Limited$0.69-0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

FUTUFutu

FUTUFutu$89.76-0.28%

Questions About WXIBF

What is the current price of WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) is trading at $4.18 per share.

What is the 52-week range for WuXi Biologics (Cayman)?

Over the past 52 weeks, WuXi Biologics (Cayman) has traded between $2.85 and $5.61.

How much debt does WuXi Biologics (Cayman) have?

As of the most recent reporting period, WuXi Biologics (Cayman) reported total debt of $444.19M.

How much cash does WuXi Biologics (Cayman) have on hand?

WuXi Biologics (Cayman) reported $1.32B in cash and cash equivalents in its most recent financial results.

What is WuXi Biologics (Cayman)’s dividend yield?

WuXi Biologics (Cayman) does not currently have a dividend yield.

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Financials at a Glance

WXIBF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About WuXi Biologics (Cayman)

WXIBF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WXIBF

What is the current price of WuXi Biologics (Cayman)?

What is the 52-week range for WuXi Biologics (Cayman)?

How much debt does WuXi Biologics (Cayman) have?

How much cash does WuXi Biologics (Cayman) have on hand?

What is WuXi Biologics (Cayman)’s dividend yield?

Premium Investing Services